Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Endocrinology
•
Pituitary Disorders
When and how do you taper off cabergoline therapy for treatment of microprolactinoma?
Answer from: at Community Practice
If patient does not desire fertility and microprolactinoma is stable or smaller, cabergoline can be tapered off.
Comments
at Northwestern University Endocrinology
The dose should be gradually tapered down to 0.5 m...
12127
Sign in or Register to read more
21564
Related Questions
When do you recommend using L-arginine stimulated copeptin testing to evaluate for central diabetes insipidus (AVP-deficiency)?
Do you recommend increased screening for hypercortisolism in older patients given recent evidence that older patients do not commonly display hallmark symptoms of Cushing's Disease?
Should we be aiming for normalization of both late-night salivary cortisol and 24hr urinary free cortisol levels when monitoring response to Cushing's disease treatment?
When do you consider using setmelanotide for treatment of hypothalamic obesity?
Should we be considering transsphenoidal surgical resection as first-line therapy for prolactinomas?
How do you approach mild prolactin elevations (20-80) in women with galactorrhea on nipple stimulation but regular menses and no plans for pregnancy?
For patients with central hypothyroidism and a clear etiology (such as recent head irradiation), do you recommend brain imaging prior to starting thyroid hormone replacement therapy?
How do you approach monitoring for autoimmune disorders in patients with surgical remission of Cushing’s disease, given the higher incidence of autoimmune disease in this population?
What is your approach to differentiating diabetes insipidus from primary polydipsia in the outpatient setting?
Do you interpret failure to develop hypernatremia with prolonged water deprivation (such as for 12 hours) as evidence against diabetes insipidus even if the urine osmolality is just below normal?
The dose should be gradually tapered down to 0.5 m...